Hara Capital
NVO icon

Hara Capital’s Novo Nordisk NVO Stock Holding History

Hara Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.46M Sell
64,784
-3,176
-5% -$146K 1.18% 27
2026
Q2 		$3.26M Sell
67,960
-26,714
-28% -$1.15M 1.72% 17
2026
Q1 		$3.59M Buy
94,674
+24,720
+35% +$1.17M 1.79% 13
2025
Q4 		$3.56M Buy
69,954
+23,537
+51% +$1.2M 1.98% 11
2025
Q3 		$2.58M Buy
+46,417
New +$2.72M 1.52% 17

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Folketrygdfondet
Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Hara Capital's NVO Position: Q3 2026 in Review

Hara Capital reduced its Novo Nordisk (NVO) stake by 4.7% in Q3 2026, selling an estimated $146K and leaving 64,784 shares worth $2.46M. The position accounts for 1.18% of the portfolio, ranked #27.

Hara Capital first reported a position in NVO in Q3 2025 and has held it in 5 quarters since. The position peaked at $3.59M in Q1 2026. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Hara Capital held 64,784 shares of Novo Nordisk worth $2.46M as of Q3 2026.
  • Hara Capital sold 3,176 Novo Nordisk shares in Q3 2026, an estimated $146K.
  • Novo Nordisk made up 1.18% of Hara Capital's portfolio in Q3 2026, its #27 holding.
  • Hara Capital first reported a position in Novo Nordisk in Q3 2025 and has held it in 5 quarters since.
  • Hara Capital's Novo Nordisk position peaked at $3.59M in Q1 2026.
  • 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Hara Capital's 13F filing for Q3 2026, filed 30 Oct 2026.